Document is current

Article History

Received: 10 September 2025

Accepted: 4 February 2026

First Online: 10 March 2026

Declarations

:

: Elizabeth Munkebjerg Stevens: None. Kirstine Vester-Glowinski: None. Lone Skov: Outside the submitted work: research funding from Bristol-Myers Squibb, Janssen Pharmaceuticals, Almirall, Sanofi, the LEO Foundation, and the Kgl. Hofbundtmager Aage Bang Foundation: honoraria as consultant and/or speaker for AbbVie, Eli Lilly, Novartis, Pfizer, LEO Pharma, Janssen, UCB, Almirall, Galderma, Stada, Bristol Myers Squibb, Takeda, and Sanofi. Mette Gyldenløve: Outside the submitted work: honoraria as consultant and/or speaker for Galderma Nordic AB and Glenmark Therapeutics. Nikolai Loft: Outside the submitted work: paid speaker for Eli Lilly, Janssen Cilag, Galderma, and Sandoz. Research funding from the LEO Foundation.

: The data that support the findings of this article are available from the corresponding author upon reasonable request.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors made substantial contributions to the work and approved the final version of the manuscript. Stevens and Loft had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Loft and Gyldenløve. Acquisition, analysis, and interpretation of data: All authors. Drafting of the manuscript: Stevens, Loft, and Vester-Glowinski. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Loft. Administrative, technical, or material support: None.